First Advantage Vs. Corcept Therapeutics Industry Stock Comparison

Buy

85

FA
First Advantage

Last Price:

19.82

Seasonality Move:

-6.56%

Buy

68

CORT
Corcept Therapeutics

Last Price:

40.92

Seasonality Move:

-0.77%

Buy

85

First Advantage (FA) is a Buy

Is First Advantage a Buy, Sell or Hold?

The current First Advantage [FA] share price is $19.66. The Score for FA is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
FA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

Buy

68

Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics a Buy, Sell or Hold?

The current Corcept Therapeutics [CORT] share price is $42.27. The Score for CORT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FA Stock Price Chart

What is First Advantage's stock price today?

The First Advantage share price today is $19.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FA is experiencing slight buying pressure.

CORT Stock Price Chart

What is Corcept Therapeutics's stock price today?

The Corcept Therapeutics share price today is $42.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.

FA Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.51	Buy
Relative Strength Index (14 RSI):	71.32	Buy
Chaikin Money Flow:	18508	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(18.2 - 19.44)	Buy
Bollinger Bands (100):	(15.87 - 18.17)	Buy

CORT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.36	Buy
Relative Strength Index (14 RSI):	82.3	Buy
Chaikin Money Flow:	670376	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(33.47 - 37.45)	Buy
Bollinger Bands (100):	(28.16 - 35.86)	Buy

FA Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	19.34	Buy
20-day SMA:	19.1	Buy
50-day SMA:	17.77	Buy
200-day SMA:	16.58	Buy
8-day EMA:	19.39	Buy
20-day EMA:	18.96	Buy
50-day EMA:	18.08	Buy
200-day EMA:	16.58	Buy

CORT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	37.44	Buy
20-day SMA:	35.75	Buy
50-day SMA:	34.88	Buy
200-day SMA:	28.43	Buy
8-day EMA:	38.24	Buy
20-day EMA:	36.43	Buy
50-day EMA:	34.68	Buy
200-day EMA:	30.05	Buy

First Advantage Earnings Growth & FA Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.09 per share, and an increase next year of $0.14 per share.

Corcept Therapeutics Earnings Growth & CORT Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.

First Advantage Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Corcept Therapeutics Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):